SEC Form 4 · accession 0001437749-18-011227
BIOLIFE SOLUTIONS INC · BLFS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Roderick De Greef
Officer — Chief Financial Officer
Period of report
May 31, 2018
Accepted (ET)
Jun 4, 2018 · 5:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000834365
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 31, 2018 | M | 10,000 | $1.64 | A | 24,583 | D | |
| Common Stock | May 31, 2018 | S | 10,000 | $10.44 | D | 14,583 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock OptionF1 | $1.64 | May 31, 2018 | M | 10,000 | D | — | Dec 20, 2021 | Common Stock | 10,000 | 136,919 | D |
| Employee Stock OptionF2 | $1.8099 | holding | — | — | — | — | May 3, 2026 | Common Stock | 234,000 | 234,000 | D |
| Employee Stock OptionF3 | $1.76 | holding | — | — | — | — | Mar 4, 2026 | Common Stock | 100,000 | 100,000 | D |
Explanation of responses
- F1The stock option vests and becomes exercisable as follows: 85,960 shares vested on March 8, 2018 and 85,959 shares will vest on March 8, 2019.
- F2The stock option vests 25% on the first anniversary of the grant date, and in 36 equal monthly installments thereafter.
- F3The stock option vests 25% on the first anniversary of the grant date and thereafter, in 36 equal monthly installments. Such options shall continue to vest regardless of whether Mr. de Greef's service with the Company continues.